STARWOOD-HOTELS
Starwood Hotels & Resorts Worldwide, Inc. (NYSE:HOT) today announced the debut of Tribute Portfolio in Europe with the addition of the Great Northern Hotel, a Tribute Portfolio Hotel. Launched this past April as Starwood’s 10th brand, Tribute Portfolio is a collection of outstanding independent hotels and resorts, promising owners, Starwood Preferred Guest ® (SPG® ) members and guests alike the ability to “Stay Independent. ” The signing of the Great Northern Hotel – a historic King’s Cross London landmark – is a significant step in the global roll-out of Tribute Portfolio and reflects the growing global trend for independent, yet dependable high-end travel experiences.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20150901005889/en/
“We are delighted to welcome the Great Northern Hotel as the first Tribute Portfolio property in Europe,” said Dave Marr, Global Brand Leader for Tribute Portfolio and Sheraton Hotels & Resorts. “The hotel has been designed with such meticulous attention to detail, and we’re excited to partner alongside Mr. Jeremy Robson as he continues to bring his independent vision to life.”
Tribute Portfolio Lands in London
Situated within the
new Western Concourse of King's Cross and just 25 meters from the
Eurostar terminus at St. Pancras International, the Great Northern is
one of the finest upscale boutique hotels in greater London. Having
first opened in 1854, the hotel has been exquisitely refurbished and
re-designed by Victorian master builder Lewis Cubitt to evoke the
glamour and grace of the building’s extraordinary past. The Cubitt rooms
feature high ceilings and large twin sash windows, filling the rooms
with an abundance of natural light, while the fun and charming Couchette
rooms serve as innovative interpretations of a traditional railway
carriage car sleeper. The Wainscot rooms, located on the top floor of
the hotel, have high mansard style ceilings and are lined with Black
American Walnut Wainscot paneling, which, along with deep aubergine
paint, create a seductive ambiance.
Guests of the Great Northern can enjoy a variety of dining options that bring to life the ambiance and flavors of English cuisine. Plum + Spilt Milk, located one flight up the hotel’s original grand staircase, offers simple British dishes using seasonal and carefully-sourced ingredients. The restaurant, whose name originates from the lively colors of the dining cars pulled by the Flying Scotsman, features 120 hand blown glass pendants and banquette-based furniture, handmade by Boffi of Milan. Designed with the aim of being one of Europe’s most glamorous railway bars, The GNH Bar opens directly into King's Cross station and features etched mirror ceilings, an organically-shaped pewter and marble bar and two grand crystal chandeliers.
“Since our launch in 2013, the Great Northern Hotel has become one of London’s finest boutique hotels,” said Jeremy Robson, Owner of the Great Northern Hotel, a Tribute Portfolio Hotel. “The restoration of the property was a dream of mine for many years, and together with my excellent team, I am incredibly proud to have created something of real value: a London landmark serving both visitors and Londoners alike. Today, our award-winning hotel joins Tribute Portfolio and the prestigious Starwood collection. We are looking forward to building on our success with this powerful brand whilst maintaining everything that makes the Great Northern Hotel a unique and much-loved property. ”
We Like What We See
As with all of the brand’s
properties, the Great Northern Hotel features a noteworthy selection of
No. ourlikes, a list comprised of distinct moments found at the hotel that
illustrate what guests love about “staying independent.” Beyond the
typical hotel brochure, these socially-sourced vignettes highlight the
secret spots, must-sees and can’t-miss experiences at each Tribute
Portfolio property.
The No. ourlikes for the Great Northern Hotel include:
- The building’s distinct exterior architecture;
- The luxurious Cubitt Room, named after the hotel’s master builder, featuring Jielde table lamps on either side of the bed;
- The whimsical luggage and door tags, which offer classic line drawings of bellman and other noteworthy hotel features;
- The King’s Cross Kiosk, with delectable must-try roast meat sandwiches;
- The self-serve Pantry located on each floor, which provides guests the perk of feeling right at home;
- Plum + Spilt Milk restaurant, offering fine British cuisine in a decidedly design-focused setting;
- The GNH Bar, with its convivial nightlife in a stylish setting, offering the signature Lady Violet cocktail, paying homage to a former resident from the hotel’s glory days.
“Tribute Portfolio is just the latest example in Starwood’s long history of brand innovation, design leadership and leading global high-end footprint,” said Michael Wale, President, Starwood Hotels & Resorts, Europe, Africa and Middle East. “Our mission is to bring great hotels in great destinations to our SPG members who make up more than half of all Starwood stays.”
Independent by Nature
An answer to both guests’ and
owners’ desire to Stay Independent
, Tribute Portfolio debuted in
April 2015 with its first hotel, the Royal Palm South Beach Miami, and
recently announced two new future locations including Coral Gables, FL
and Ft. Lauderdale, FL. Firmly anchored in the four-star, upper upscale
category, Tribute Portfolio allows owners of distinct properties to
maintain their independent spirit, while benefiting from Starwood’s
powerful distribution, loyalty and sales platforms.
Starwood aims to grow the brand to 100 hotels by 2020, with locations in high-demand destinations and markets where SPG members travel. For more information and to follow along, please visit www.tributeportfolio.com .
No. No. No.
About Tribute Portfolio
New
from Starwood Hotels & Resorts, Tribute Portfolio is comprised of
exceptional independent hotels around the globe, offering guests and
owners the ability to “Stay Independent.” From boutique resorts to urban
destination properties, guests can enjoy access to outstanding four
star, upper upscale hotels with an indie spirit while benefitting from
the award-winning Starwood Preferred Guest (SPG) program. Launched in
April 2015 as Starwood’s 10th brand and second collection of independent
hotels, Starwood plans to grow the Tribute Portfolio brand to 100 hotels
by 2020. For more information on Tribute Portfolio, please visit www.tributeportfolio.com
.
Follow along to Stay Independent: @TributePortfolio
on
Instagram, @TributePRTFLO
on
Twitter, www.tumblr.com/TributePortfolio
and www.facebook.com/TributePortfolio
.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150901005889/en/
Contact:
Media Contact:
Julien Guitard, Tel. +32 2 204 5160
Associate
Director Communications – Europe, Africa & Middle East
Starwood
Hotels & Resorts
Julien.Guitard@starwoodhotels.com
www.starwoodmediacentre.com
or
Nicola
McShane, +44 (0) 20 7290 7105
Acting Regional Director
Communications – Western Europe
Starwood Hotels & Resorts
Nicola.Mcshane@starwoodhotels.com
www.starwoodmediacentre.com
or
Louise
Toye, +44 (0)207 290 7107
Director of Communications – UK & Ireland
Starwood
Hotels & Resorts
Louise.Toye@starwoodhotels.com
www.starwoodmediacentre.com
or
Tabitha
Russell / Georgia Lowther, +44 (2) 208 600 3600
Sauce Communications
Tabitha@saucecommunications.com
/ Georgia@saucecommunications.com
Link:
Information om Business Wire
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis16.7.2025 07:00:00 CEST | Press release
- First patient enrolled in INFLAM MOTION, a global randomized Phase 2a trial including 129 knee osteoarthritis patients - 4P004 to be evaluated over 3 months for dual efficacy: symptom relief and synovial health improvement via contrast-enhanced MRI - Topline results expected in the second half of 2026 4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatments that modify the natural course of knee osteoarthritis (OA), today announced that the first patient has been enrolled in Phase 2a clinical trial, INFLAM MOTION. The study will evaluate 4P004, an intra-articular GLP-1 analog, as a potential first-in-class therapeutic candidate for knee osteoarthritis. INFLAM MOTION is a multicenter, randomized, double-blind, placebo-controlled Phase 2a trial planned to be conducted across Europe, the United States, and Canada. A total of 129 patients worldwide diagnosed with knee OA will be enrolled to evaluate, for the first time in humans, the efficacy of 4P
Belkin Achieves Qi2.2 Certification for Its Upcoming Products, Unlocking the Future of 25W Wireless Charging15.7.2025 19:06:00 CEST | Press release
With Qi2.2 certification, Belkin reinforces its commitment to quality, safety, and performance for the next generation of wireless charging Belkin, a leading consumer electronics brand for over 40 years, today announced it has received official Qi2.2 certification from the Wireless Power Consortium (WPC) for its upcoming products. As one of the first accessory brands to deliver Qi2.2-certified devices, Belkin is helping bring the next generation of wireless charging to market – enabling faster wireless charging speeds, broader compatibility, and improved performance for consumers. Belkin’s close partnership with the WPC since 2015 has been instrumental in bringing these advancements to consumers. As an early adopter and long-time contributor to WPC standards, Belkin was selected as one of a small group of trusted manufacturers to test and certify Qi2.2 products ahead of the broader industry rollout. All Belkin products undergo rigorous safety, quality, and performance testing. The comp
Cessna Grand Caravan EX to Feature New Executive Interior Options, Expanding Opportunities for Elevated Missions15.7.2025 18:05:00 CEST | Press release
The legendary Cessna Grand Caravan EX will now feature three new executive interior schemes for customers to select when designing their aircraft cabin. The Lunar, Obsidian and Saddle Sport interiors join the existing Canyon and Savanna schemes, providing a broader range of standard choices. The new interior options are available to customers starting this month and allow them to further tailor the interior of their aircraft based on their personal preference or mission. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250715021096/en/ Cessna Grand Caravan EX to feature new executive interior options, expanding opportunities for elevated missions (Photo Credit: Textron Aviation) The Cessna Grand Caravan EX is designed and manufactured by Textron Aviation Inc., a Textron Inc. (NYSE:TXT) company. Premium versions of each of the new interiors are also available, featuring quilted seat stitching and plush carpet, providing an elev
7 Million Tokens Sells Out in less than One Hour—$MBG Token Pre-Sale Shatters Expectations15.7.2025 17:27:00 CEST | Press release
MultiBank Group, the world’s largest and most regulated financial derivatives institution, has set a new benchmark in digital asset launches. The Group’s $MBG Token Pre-Sale sold out in less than one hour with all 7 million tokens fully subscribed across MultiBank.io and Uniswap. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250715055611/en/ The Group’s $MBG Token Pre-Sale sold out in less than one hour with all 7 million tokens fully subscribed across MultiBank.io and Uniswap. Commenting on the success of the Pre-Sale, Naser Taher, Founder and Chairman of MultiBank Group, said: “The sell-out of our initial $MBG Token offering in less than one hour is a decisive validation of our vision. In a market saturated with speculation, the response we received confirms that institutional-grade transparency, regulatory integrity, and asset-backed value are what investors are now demanding. $MBG is here for the long term, reflecting t
First Patient Enrolled in National Cancer Institute’s Vanguard Study Evaluating Guardant Health’s Shield Multi-Cancer Detection Test15.7.2025 17:01:00 CEST | Press release
Study addressing feasibility of using multi-cancer detection tests in future trials aims to enroll up to 24,000 participantsShield MCD reviewed by FDA as part of NCI’s investigational device exemption (IDE) Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that patient enrollment has begun in the National Cancer Institute (NCI)’s Vanguard Study to evaluate emerging multi-cancer detection (MCD) technology. Guardant’s Shield™ MCD test was selected for use in the four-year study, which aims to enroll up to 24,000 patients and evaluate the use of MCD tests—blood tests that can screen for several types of cancer simultaneously—in future randomized controlled trials. Guardant’s Shield MCD test was chosen for the study based on the overall performance of its Shield platform in detecting 10 cancer types, including lung, breast, colorectal, prostate, bladder, ovarian, pancreatic, esophageal, liver and gastric. The data were presented at the 2025 American
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.
Besøg vores nyhedsrum